1. Home
  2. GCV vs NRXS Comparison

GCV vs NRXS Comparison

Compare GCV & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Convertible and Income Securities Fund Inc. (The)

GCV

Gabelli Convertible and Income Securities Fund Inc. (The)

SELL

Current Price

$3.70

Market Cap

77.8M

Sector

Finance

ML Signal

SELL

Logo Neuraxis Inc.

NRXS

Neuraxis Inc.

HOLD

Current Price

$4.42

Market Cap

76.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GCV
NRXS
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
77.8M
76.9M
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
GCV
NRXS
Price
$3.70
$4.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
★ $11.00
AVG Volume (30 Days)
59.5K
★ 146.5K
Earning Date
01-01-0001
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 22.13
EPS
★ N/A
N/A
Revenue
N/A
★ $3,569,282.00
Revenue This Year
N/A
$118.53
Revenue Next Year
N/A
$101.28
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 32.89
52 Week Low
$3.50
$2.50
52 Week High
$4.80
$9.33

Technical Indicators

Market Signals
Indicator
GCV
NRXS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
GCV
NRXS

About GCV Gabelli Convertible and Income Securities Fund Inc. (The)

GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC is a diversified closed-end management investment company. Its investment objective is to seek a high level of total return through a combination of current income and capital appreciation by investing in convertible securities. The company invests in various portfolios such as Health Care, Financial Services, Real Estate Investment Trust, Energy and Utilities, Telecommunications, Food and Beverage, Aerospace and Automotive, and others. All the operation of the group is operated through the regions of the United States.

About NRXS Neuraxis Inc.

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Share on Social Networks: